162 related articles for article (PubMed ID: 34508259)
21. GuideMaker: Software to design CRISPR-Cas guide RNA pools in non-model genomes.
Poudel R; Rodriguez LT; Reisch CR; Rivers AR
Gigascience; 2022 Apr; 11():. PubMed ID: 35365834
[TBL] [Abstract][Full Text] [Related]
22. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
Graf R; Li X; Chu VT; Rajewsky K
Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
[TBL] [Abstract][Full Text] [Related]
23. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.
Darcis G; Binda CS; Klaver B; Herrera-Carrillo E; Berkhout B; Das AT
Viruses; 2019 Mar; 11(3):. PubMed ID: 30871200
[TBL] [Abstract][Full Text] [Related]
24. Single transcript unit CRISPR 2.0 systems for robust Cas9 and Cas12a mediated plant genome editing.
Tang X; Ren Q; Yang L; Bao Y; Zhong Z; He Y; Liu S; Qi C; Liu B; Wang Y; Sretenovic S; Zhang Y; Zheng X; Zhang T; Qi Y; Zhang Y
Plant Biotechnol J; 2019 Jul; 17(7):1431-1445. PubMed ID: 30582653
[TBL] [Abstract][Full Text] [Related]
25. Exploiting off-targeting in guide-RNAs for CRISPR systems for simultaneous editing of multiple genes.
Ferreira R; Gatto F; Nielsen J
FEBS Lett; 2017 Oct; 591(20):3288-3295. PubMed ID: 28884816
[TBL] [Abstract][Full Text] [Related]
26. Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells.
Ting PY; Parker AE; Lee JS; Trussell C; Sharif O; Luna F; Federe G; Barnes SW; Walker JR; Vance J; Gao MY; Klock HE; Clarkson S; Russ C; Miraglia LJ; Cooke MP; Boitano AE; McNamara P; Lamb J; Schmedt C; Snead JL
Nat Methods; 2018 Nov; 15(11):941-946. PubMed ID: 30297964
[TBL] [Abstract][Full Text] [Related]
27. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
Kumar R; Tiwari K; Saudagar P
Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
[TBL] [Abstract][Full Text] [Related]
28. Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing.
Replogle JM; Norman TM; Xu A; Hussmann JA; Chen J; Cogan JZ; Meer EJ; Terry JM; Riordan DP; Srinivas N; Fiddes IT; Arthur JG; Alvarado LJ; Pfeiffer KA; Mikkelsen TS; Weissman JS; Adamson B
Nat Biotechnol; 2020 Aug; 38(8):954-961. PubMed ID: 32231336
[TBL] [Abstract][Full Text] [Related]
29. Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing.
Liu X; Xiong W; Qi Q; Zhang Y; Ji H; Cui S; An J; Sun X; Yin H; Tian T; Zhou X
Nucleic Acids Res; 2022 May; 50(8):4769-4783. PubMed ID: 35446403
[TBL] [Abstract][Full Text] [Related]
30. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
[TBL] [Abstract][Full Text] [Related]
31. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
Wang Q; Ui-Tei K
Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
[TBL] [Abstract][Full Text] [Related]
32. Comparative optimization of combinatorial CRISPR screens.
Li R; Klingbeil O; Monducci D; Young MJ; Rodriguez DJ; Bayyat Z; Dempster JM; Kesar D; Yang X; Zamanighomi M; Vakoc CR; Ito T; Sellers WR
Nat Commun; 2022 May; 13(1):2469. PubMed ID: 35513429
[TBL] [Abstract][Full Text] [Related]
33. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
Fu Y; Reyon D; Joung JK
Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
[TBL] [Abstract][Full Text] [Related]
34. SeqCor: correct the effect of guide RNA sequences in clustered regularly interspaced short palindromic repeats/Cas9 screening by machine learning algorithm.
Liu X; Yang Y; Qiu Y; Reyad-Ul-Ferdous M; Ding Q; Wang Y
J Genet Genomics; 2020 Nov; 47(11):672-680. PubMed ID: 33451939
[TBL] [Abstract][Full Text] [Related]
35. Multiplexed
Ophinni Y; Miki S; Hayashi Y; Kameoka M
Viruses; 2020 Oct; 12(11):. PubMed ID: 33126728
[TBL] [Abstract][Full Text] [Related]
36. Massively parallel CRISPR off-target detection enables rapid off-target prediction model building.
Tian R; Cao C; He D; Dong D; Sun L; Liu J; Chen Y; Wang Y; Huang Z; Li L; Jin Z; Huang Z; Xie H; Zhao T; Zhong C; Hong Y; Hu Z
Med; 2023 Jul; 4(7):478-492.e6. PubMed ID: 37279759
[TBL] [Abstract][Full Text] [Related]
37. Genome scale screening identification of SaCas9/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection.
Wang Q; Liu S; Liu Z; Ke Z; Li C; Yu X; Chen S; Guo D
Virus Res; 2018 May; 250():21-30. PubMed ID: 29625148
[TBL] [Abstract][Full Text] [Related]
38. Multiplexed CRISPR technologies for gene editing and transcriptional regulation.
McCarty NS; Graham AE; Studená L; Ledesma-Amaro R
Nat Commun; 2020 Mar; 11(1):1281. PubMed ID: 32152313
[TBL] [Abstract][Full Text] [Related]
39. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
40. Massively parallel Cas13 screens reveal principles for guide RNA design.
Wessels HH; Méndez-Mancilla A; Guo X; Legut M; Daniloski Z; Sanjana NE
Nat Biotechnol; 2020 Jun; 38(6):722-727. PubMed ID: 32518401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
